Next Quarterly Earnings
Monday, November 9, 2026
CW 46
Pre-Market
In 74 days
Pre-market — typically before 3:30 p.m. German time (before the US open at 9:30 a.m. New York time).
Beam Therapeutics
Beam Therapeutics is a leading US biopharmaceutical company employing precise base editing, a revolutionary form of gene editing. The company develops innovative therapeutics to treat severe genetic diseases by correcting individual base pairs within the genome. Its goal is to deliver groundbreaking medicines to patients and transform medicine.
Frequently asked questions
When will Beam Therapeutics report its next quarterly earnings?
Beam Therapeutics is scheduled to report its next quarterly earnings on 11/09/2026. Pre-market — typically before 3:30 p.m. German time (before the US open at 9:30 a.m. New York time).
When did Beam Therapeutics last report quarterly earnings?
Beam Therapeutics last reported quarterly earnings on 8/4/2026 (Q2 2026). Earnings per share (EPS) came in at -1.18 USD.
How does Beam Therapeutics stock react to earnings?
Across its last 3 earnings reports, Beam Therapeutics stock moved by ±7.6% on average the following day. The largest reaction was +14% on 02/24/2026; 1 of 3 reactions were positive.
How often has Beam Therapeutics beaten expectations?
Beam Therapeutics has beaten analyst EPS estimates in 3 of its last 5 evaluated quarters (beat rate: 60%).
How do I add the Beam Therapeutics earnings dates to my calendar?
Use the 'Subscribe in calendar' button on this page to add all dates to Google Calendar, Apple Calendar or Outlook. Dates update automatically when they change.
All Dates
Earnings statistics
Stock reaction to earnings
±7.6%
Avg. next-day move
+14%
Largest move (02/24/2026)
33.3%
Share of positive reactions
±6.6%
Avg. move after 7 days
Basis: price reactions to the last 3 report dates (close to close).
Estimates vs. results
3/5
Quarters above estimates
60%
Beat rate
+67.1%
Avg. EPS surprise
Basis: 5 quarters with an analyst estimate and reported EPS.
Past price reactions are not a reliable indicator of future performance.
Company Information
Name
Beam Therapeutics
Country
🇺🇸
More Financial Information